Cytes Biotechnologies attended the 2019 BioAsia, which was held in Hyderabad (India) from 25th to 27th February. In this edition the theme was "Disrupt the Disruption" where the highlight was the urgency to take appropriate action to move forward in creative thinking, redesigning business models, etc., to lead the future success through agility and innovation.
2019 BioAsia conference enabled Cytes Biotechnologies to connect and interact with more than 800 corporates and over 70 high profile global thought leaders from more than
We are happy to announce we hired Dr. Natalia Sánchez-Romero to become the Director of our R&D department who will help us to give you an even better technical support.
Dr. Natalia Sanchez-Romero is originally from Spain where she obtained her Degree in Biotechnology, with a Master's Degree in Management and Administration of Biotechnological companies (Francisco de Vitoria’s University) and a Master's Degree in Genetics and Cell Biology (Complutense University of Madrid).
After that, she engaged in her doctoral dissertation work, after being awarded a doctoral scholarship grant from the Spanish government in 2013 to develop her PhD and she obtained an international Ph.D in Biomedicine and Biotechnology in June 2017. From June 2017 until December 2018, she worked as a postdoctoral fellow at the Health Research Institute of Aragon (IIS Aragon) in Zaragoza, focused on the biology of IGF1 in liver and lung organoids, and on novel neovascularization strategies in the bioengineering of these solid organs.
After the successful attendance at BioJapan 2017, Cytes Biotechnologies has participate again in the event. Our CTO Estephan Arredondo was delighted to meet our customers and new contacts there to talk about potential synergies.
The Partnering system was shared between BioJapan and Regenerative Medicine Japan, and the participants could reach a wide range of potential partners; over 9.000 meetings took place in the event.
Cytes Biotechnology has successfully attended a Workshop about Japan culture and business in Germany to help design our strategy for that country. This workshop was part of the EIT Health initiative Start.Smart.Japan, a full-year training program focused in speed-up market of European life science SMEs in Japan.
Thanks to our partnership with PRIMACYT we have been the 54th Congress of the European Societies for Toxicology (EUROTOX 2018) from the 2nd to the 5th of September, presenting our products.
The theme was "Toxicology out of the Box", and included outstanding keynote lectures.
Cytes Biotechnologies attended the 2018 BIO INTERNATIONAL CONVENTION which was held in Boston (USA) from 4th to 7th June. In this 25th anniversary, 7.900 delegates from 3.900 companies participated in more than 46.900 partnering meetings; the largest number of attendees in 10 years, and hosting the largest number of BIO One-on-One Partnering meetings, setting a Guinness World Records for the Largest Business Partnering meeting.
Cytes Biotechnologies had access to the partnering system and arrangement of meetings in the Business Forum interacting with international biotechnology businesses and organizations. And also, had its own booth in the Spanish pavilion, Catalan BioRegion, managed through ICEX.
Cytes Biotechnologies attended for the first time BioJapan in its 19th annual fair, in Yokohama (2017). BioJapan is a benchmark fair in Asia for the global biotechnology industry which brings professionals and executives from biotechnologies companies. In 2017, over 900 organizations from 33 countries and regions participated in this event, holding more than 8.500 business meetings over the fair days.
Cytes Biotechnologies had the occasion to interact with international biotechnology businesses and organizations to advance new alliances and collaboration opportunities, having its own booth in Catalonian BioRegion, in the Spanish pavilion.